---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-011346"
form_type: "8-K"
ticker: "IDYA"
cik: "0001676725"
company_name: "IDEAYA Biosciences, Inc."
filed_at: "2024-01-19T23:59:59+00:00"
generated_at: "2026-06-06T21:20:35.104209+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# IDEAYA Biosciences enters $350M at-the-market stock offering with Jefferies

## Summary
- Up to $350M in common stock may be sold from time to time through Jefferies as sales agent.
- Jefferies receives 3% commission on gross proceeds; Company sets sale parameters.
- Shares issued under existing Form S-3 registration statement; prospectus supplement filed Jan 19, 2024.
- ATM program provides at-the-market offering flexibility; no minimum offering amount required.

## SEC filing metadata
- accession: 0001193125-24-011346
- form_type: 8-K
- ticker: IDYA
- cik: 0001676725
- company_name: IDEAYA Biosciences, Inc.
- filed_at: 2024-01-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676725/000119312524011346/0001193125-24-011346-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676725/000119312524011346/d581989d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-011346
- JSON: https://secwatch.observer/filing/0001193125-24-011346.json
- Plain text: https://secwatch.observer/filing/0001193125-24-011346.txt

## Key facts
- Material Agreements
  IDEAYA Biosciences, Inc. entered into Open Market Sales Agreement with Jefferies LLC valued at up to $350,000,000 (effective 2024-01-19).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Jefferies LLC
  - Value: up to $350,000,000
  - Effective: 2024-01-19
  source text: On January 19, 2024, IDEAYA Biosciences, Inc. (the “Company”) entered into an Open Market Sales Agreement (the “Sales Agreement”) with Jefferies LLC (“Jefferies”), with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the “Common Stock”), having aggregate gross proceeds of up to $350.0 million (the “Shares”) through Jefferies as its sales agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1676725/000119312524011346/0001193125-24-011346-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.